Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 7 / 70
299 controlsThe study evaluated 299 controls without acquired drug resistance among persons living with HIV receiving combination antiretroviral therapy.
NigeriaVIH/sidaobserved 2004–2011published 2020AIDS research and therapyPubMeddocument of 7 observations
25 %Two (25%) of the eight participants with presumed ocular toxoplasmosis (POT) were HIV-seropositive.
Nigeriapresumed ocular toxoplasmosis · VIH/sidapublished 2021Ethiopian journal of health sciencesPubMeddocument of 9 observations
22.5 %Among 726 TB patients' records reviewed at the DOTs centre in Federal Medical Centre Abeokuta between January 2015 and December 2019, 186 (22.5%) were co-infected with HIV.
Nigeriatuberculose · VIH/sidaobserved January 2015 to December 2019published 2022The journal of the Royal College of Physicians of EdinburghPubMeddocument of 6 observations
15 casesThe prevalence of HIV seropositivity among pregnant women in the study was 15 out of 900 participants.
NigeriaVIH/sidapublished 2021Viral immunologyPubMeddocument of 8 observations
4.8 %HIV prevalence among 8306 consenting adults aged ≥15 years in Akwa Ibom state, Nigeria, was 4.8%.
NigeriaVIH/sidaobserved 2017published 2021Journal of the International AIDS SocietyPubMeddocument of 9 observations
0 %The missed opportunity for antiretroviral therapy initiation among antenatal care attendees was 0% in Adamawa State in Nigeria in 2019.
NigeriaVIH/sidaobserved 2019published 2023AIDS carePubMeddocument of 7 observations
0.24 AORPeople living with HIV had adjusted odds ratio (AOR) of 0.24 for being hungry but not eating, with 95% confidence interval 0.20–0.30.
NigeriaVIH/sidapublished 2022AIDS and behaviorPubMeddocument of 4 observations
53 %A majority of HIV-infected patients (53.0%) had a CD4 count of less than 500 cells/ml.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 4 observations
48.4 %Of 3495 key populations living with HIV in KP-CBART, 48.4% (n = 1691) had a viral load test.
NigeriaVIH/sidapublished 2021PloS onePubMeddocument of 7 observations
64.1 %Among 168 people living with HIV (PLHIV) studied, 64.1% had fertility desire.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations
2.01 AORRespondents living with HIV had higher odds for physical violence (AOR: 2.01; 95% CI: 1.46–2.76; p < 0.001).
NigeriaVIH/sidaobserved 2021published 2022BMC public healthPubMeddocument of 12 observations
13.5 %Depression was cited as a reason for antiretroviral therapy non-adherence in 57 cases (13.5%) among female sex workers who died from HIV/AIDS.
NigeriaVIH/sidaobserved 2022-02-01 to 2023-02-28published 2026International journal of environmental research and public healthPubMeddocument of 10 observations
3.88 AORLiving with HIV was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 3.88).
NigeriaCOVID-19 · VIH/sidaobserved 2020published 2022Frontiers in public healthPubMeddocument of 10 observations
28 %Among 224 HIV-1 infected samples from 6 Nigerian cities, the subtype distribution was 28% G.
NigeriaVIH/sidapublished 2016MedicinePubMeddocument of 7 observations
36.91 yearsThe mean age of HIV-infected participants in Port Harcourt was 36.91 years.
NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 4 observations
1,342.8 visits_per_monthMean monthly clinic attendance declined from 1,342.8 ± 220.10 visits pre-MMD6 to 1,191.33 ± 309.10 visits post-MMD6.
NigeriaVIH/sidapublished 2023African journal of AIDS research : AJARPubMeddocument of 5 observations
92.7 %92.7% of female artisans in Ibadan, Nigeria had a high level of knowledge about HIV.
NigeriaVIH/sidapublished 2025Women's health (London, England)PubMeddocument of 7 observations
91 %Approximately 91% (421 of 461) of those who received viral load results at month 12 post-enrollment were virally suppressed.
NigeriaVIH/sidaobserved month 12published 2024BMC public healthPubMeddocument of 6 observations
116,138 individuals116,138 individuals were tested for HIV before the transition period (January–June 2022).
NigeriaVIH/sidaobserved January–June 2022published 2025BMC health services researchPubMeddocument of 9 observations
2.1 %The North-Western zone of Nigeria recorded an HIV prevalence rate of 2.1%.
NigeriaVIH/sidapublished 2021Nigerian journal of clinical practicePubMeddocument of 7 observations
8 facilitiesBetween baseline (2018) and study-end (May 2022), viral load suppression coverage increased in 8 of the 10 study facilities.
NigeriaVIH/sidaobserved 2018 to May 2022published 2023BMJ global healthPubMeddocument of 4 observations
27.4 %Unnecessary drug therapy accounted for 27.4% (n=59) of the 215 drug therapy problems identified among PLWH in the study.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 11 observations
20 percentage_pointsThe coverage of antenatal HIV testing in Nigeria grew by 20 percentage points, from 50.1% to 70.5%, between 2013 and 2017.
NigeriaVIH/sidaobserved 2013 to 2017published 2021Journal of public health (Oxford, England)PubMeddocument of 3 observations
85 %Sub-Saharan Africa is home to 85% of children and adolescents living with HIV globally.
NigeriaVIH/sidapublished 2025International journal of adolescent medicine and healthPubMeddocument of 6 observations
336 persons336 (74.5%) participants had normal visual acuity.
NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.